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Abstract
Atrial fibrillation (AF), which causes severe health problems, is a multi-factor disor-
der and is increasing day by day. AF is known to be one of the most common cardiac 
arrhythmias in clinical practice. AF can also be described as a cardiac dysrhythmia that 
causes severe cardiovascular morbidity and mortality. AF is known as an independent 
risk factor for death and it occurs a significant risk of morbidity due to stroke. There are 
many diseases that contribute to the development of AF. Diseases such as aging, heart 
failure, heart valve disorders, myocardial infarction, hypertension and diabetes mellitus 
are important factors in the development of structural AF. It is a known fact that AF 
prevalence increases with age. The mechanism underlying of AF is not fully understood, 
but genetic factors play an important role in the pathogenesis of this disease. There have 
been many studies aimed at investigating the genetic basis of AF, especially in recent 
years. In these studies, many mutations and variants have emerged which are identified 
as genetic risk factors in the development of AF. Identification of gene polymorphisms 
that play a role in the development of AF will be an important guide in the development 
of new therapies for the treatment of this condition.
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1. Introduction
AF, which has a significant morbidity and mortality rate, is a multifactorial disorder as one 
of the most common cardiac arrhythmias [1, 2]. This cardiac arrhythmia affects 1–2% of the 
general population. AF is an increasingly prevalent dysrhythmia and is associated with many 
cardiac risk factors. Disorders such as hypertensive, ischemic or structural heart diseases are 
important risk factors for AF [3].
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
The underlying mechanisms in the development of AF are still not fully understood, but a 
heterogeneous model plays an important role in the pathophysiology of this disease. This 
heterogeneous model is based on the interaction of multiple substrates and triggers [3].
There are many studies showing that genetic factors play an important role in the pathogen-
esis of AF. Monogenic mutations known to be associated with AF have been identified. A total 
of 25 gene mutations proven to be associated with AF have been identified. Genome-wide 
association studies (GWAS) have been conducted to investigate AF genetics, and these studies 
have shown that single nucleotide polymorphisms play a very important role in the develop-
ment of AF. Several single nucleotide polymorphisms associated with AF predisposition have 
been identified in these GWAS studies [3].
AF is an electrical disease caused by defects in ionic currents, and a variety of studies have 
been undertaken to determine the genetic causes of these electrical illnesses. Studies con-
ducted to investigate the hereditary predisposition of AF found that the development of AF 
in pups with AF detected in their parents was found. Even though disorders such as hyper-
tension, myocardial infarction and diabetes mellitus, which are important risk factors for the 
development of AF, are regulated, they still have the risk of developing fourfold AF [3].
In many genetic studies, variants known to be associated with AF have emerged. These vari-
ants are formed as a result of abnormalities in genes encoding cardiac gap junctions, signal-
ing molecules, ion channels and auxiliary subunits. In addition, gene polymorphisms may 
cause loss of function in genes that encode proteins contributing to cardiac depolarization or 
repolarization leading to AF’s increased sensitivity, are also genetic risk factors that play an 
important role in the development of AF [3].
The purpose of this chapter is to give general information about AF and compiling the studies 
made with the aim of determining the gene polymorphisms that can play an important role 
in the development of AF.
2. Renin angiotensin aldosterone gene polymorphism
The renin angiotensin aldosterone system (RAAS) plays an important role in the regula-
tion of humoral regulation. RAAS, which is also important in the regulation of blood pres-
sure, cardiovascular homeostasis, fluid and electrolyte balance such as hypertension, heart 
failure and arrhythmia, plays an important role in the pathophysiology of various cardio-
vascular diseases. Renin, an acid protease synthesized by renal juxtaglomerular cells, is 
involved in circulation through the renal vein. A decrease in renal blood flow or a decrease 
in plasma sodium levels leads to an increase in renin secretion. Renin plays a key role in 
the production of angiotensin I in plasma or tissues. It is provided that renin is converted 
to angiotensin II by angiotensin-converting enzyme (ACE). Angiotensinogen (AGT), the 
original subtype of renin, is an important source of angiotensin II. Angiotensin II functions 
by binding to the angiotensin II receptor on fibroblasts. Angiotensin II plays an important 
role in enhancing the synthesis and secretion of collagen types I and III in the regulation of 
proliferation of fibroblasts. Angiotensin II induces aldosterone release, resulting in myocyte 
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necrosis and susceptible fibrosis. RAAS is functioning via angiotensin II. Angiotensin II is 
involved in the elevation of blood pressure in the systemic arterial and venous systems and 
in the increase of blood return to the heart. It increases the central sympathetic activity by 
increasing the oscillation from the sympathetic nerve endings. Thus, synthesis and release 
of aldosterone is regulated. RAAS, which plays a role in atrial remodeling and pathogen-
esis of AF, is an important regulator. There are not many studies aiming to investigate the 
relationship between RAAS gene polymorphisms and the risk of developing AF. In a study 
conducted by Tsai et al., it was determined that the polymorphisms occurring in RAAS 
genes increased the susceptibility to AF development as a result of association with envi-
ronmental factors leading to elevated atrial pressures. RAAS gene polymorphisms include 
ACE insertion/deletion (I/D), AGT (G-217A, A-20C, G-7A, M235T and T174M) and ATR1 
A1166C gene polymorphisms. In a study aiming to investigate the association of these poly-
morphisms with AF, in exon 2 of the AGT gene, the M235 allele, a significant relationship 
was found between haploids associated with the G-6 and G-217 alleles in the promoter 
region and AF development risk [4, 5].
2.1. ACE (I/D) gene polymorphism
The 21-kilobase pair (kbp) long ACE gene locates on chromosome 17q23. This gene consists 
of 26 exons and 25 introns. The ACE (I/D) gene polymorphism is characterized by I/D of 287 
base pairs in the 16th intron of the ACE gene. The genotypes of ACE (I/D) gene polymorphism 
differ in terms of ACE plasma and tissue levels. The DD genotype of the ACE (I/D) gene poly-
morphism is associated with high cellular ACE activity, which leads to myocardial fibrosis, so 
myocardial fibrosis develops. There are studies showing that ACE (I/D) gene polymorphism 
is associated with the risk of developing AF. There is a positive relationship between DD 
genotype and ACE activity of ACE (I/D) gene polymorphism. As a result of this relationship, 
angiotensin II level increases and myocardial hypertrophy, arrhythmia can develop. In the 
study carried out by Zhang and colleagues found a significant association between DD geno-
type of the ACE (I/D) gene polymorphism and increased AF. In another study conducted by 
Topal et al., a significant relationship was found between the incidence of ACE Alu D and 
increased AF [2].
2.2. ACE 2350G/A (rs4343) gene polymorphism
One of the ACE gene polymorphisms from the AF associated genes is the ACE 2350G/A 
(rs4343) polymorphism, and this polymorphism has a significant effect on the plasma ACE 
concentration. The ACE 2350G/A (rs4343) gene polymorphism is a synonymous mutation that 
is accepted as silent. There is insufficient study to investigate the relationship between ACE 
2350G/A (rs4343) gene polymorphism and the risk of developing AF. In a study conducted by 
Jiang et al. in a Chinese population, the A allele of ACE 2350G/A (rs4343) gene polymorphism 
has been associated with the risk of developing AF in patients with essential hypertension. 
ACE 2350G/A (rs4343) polymorphic locus do not effect expression directly of ACE mRNA 
or it has not functional variant. It is assumed that there may be link imbalance between this 
fragment and an unknown DNA fragment acting as a muffler. In order to be able to identify 
gene loci in this linkage disequilibrium, a large number of studies have to be performed [1].
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2.3. Angiotensin II type 1 receptor and angiotensin-converting enzyme 2 gene 
polymorphisms
RAAS, which plays an important role in the pathophysiology of AF in the structural 
and electrical remodeling of the atrium, contains ACE/angiotensin II/AGTR1 and ACE2/
angiotensin (1–7)/ MAS axes. These axes regulate myocardial hypertrophy, fibrosis and 
remodeling. ACE/angiotensin II/AGTR1 and ACE2/angiotensin (1–7)/MAS axes have been 
found to play an important role in AF pathogenesis. Angiotensin II is the most vasoactive 
component of RAAS, and angiotensin II, which causes increased myocardial fibrosis and 
hypertrophy, may contribute to AF development. Angiotensin II, an important signaling 
molecule of RAAS, plays a role in cardiovascular effects via AGTR1. AGTR1, G-protein is a 
bound receptor and has been associated with some disorders such as heart failure, prehy-
pertension and stroke. There are studies showing that in AF patients AGTR1 levels increase 
in the left atrium. In a study conducted with Chinese Han population, the roles of AGTR1 
rs1492100, rs1492099, rs1492097 and rs3772616 gene polymorphisms in AF development 
were investigated. A significant correlation was found between rs1492099 gene polymor-
phism from these polymorphisms and the development of structural AF. The ACE2 gene 
shows the X chromosome. In a study conducted by Freg et al., ACE2 expression was found 
to be significantly reduced in patients with chronic AF. In contrast, it is observed that atrial 
tissue angiotensin II levels were also significantly elevated. In another study with Chinese 
Han population, the effects of AGTR1 and ACE2 gene polymorphisms development of 
structural AF were examined. It is thought that polymorphisms occurred in this gene may 
be genetic risk factors in the development of structural AF in the Chinese Han male popula-
tion. Also, it has been shown that ACE2 and AGTR1 genes are associated in patients with 
structural AF [6].
2.4. Aldosterone synthase 344 C/T gene polymorphism
Aldosterone synthase (CYP112B2) is an enzyme that plays an important role in the synthesis 
of aldosterone. CYP112B2 is the mitochondrial P450 oxidase found in the adrenal cortex 
of the zona glomerulosa. Aldosterone plays an important role in regulation of ion motions 
and collagen expression, including myocardial remodeling. Delayed or reversed myocardial 
remodeling is achieved by the aldosterone inhibitor, thus can prevent AF. In a study by Goette 
et al., there was a positive relationship between elevation of AF and aldosterone levels. The 
CYP112B2 gene is 7 kilobases long and locates on chromosome 8q22. This gene consists of 9 
exons and 8 introns. The CYP112B2-344 C/T gene polymorphism is characterized by a C/T 
substitution in the −344 position in the promoter region of the CYP112B2 gene. Several stud-
ies have been conducted to investigate the relationship between CYP112B2-344 C/T gene 
polymorphism and hypertension. In some studies, CYP112B2-344 C/T gene polymorphism 
has been identified as a genetic risk factor for hypertension and myocardial hypertrophy. 
However, a limited number of studies have been conducted to investigate the relationship 
between CYP112B2-344 C/T gene polymorphism and AF. In a study conducted by Lu et al., 
no significant relationship was found between CYP112B2-344 C/T gene polymorphism and 
AF development risk. In the study conducted by Shuxin Hou et al., there were no significant 
differences in CYP112B2-344 C/T gene polymorphism genotype distributions between AF 
patients and healthy control groups. The CYP112B2-344 C/T gene polymorphism has been 
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found to be associated with an increase in C allele binding to steroidogenic transcription 
factor 1 and thus an increase in CYP112B2 activity. In a study conducted by Amir et al., 
CYP112B2-344 C/T gene polymorphism CC genotype was found to be an independent risk 
factor for AF in patients with heart failure. In a study in China Han population, conducted 
by Huang et al., found that CYP112B2-344 C/T gene polymorphism is not a genetic risk 
factor in the development of AF in patients with hypertensive heart disease. In a study per-
formed by Zhang et al., the significant relationship is not also found between CYP112B2-344 
C/T gene polymorphism and AF development [2]. It is presented primer sequences that used 
to determine AGTR1, ACE2, AGT, ACE (I/D) and CYP112B2-344C/T gene polymorphisms 
in Tables 1 and 2.
3. Nitric oxide synthase gene polymorphisms
The major products of cellular metabolism are reactive oxygen species (ROS) and reactive 
nitrogen products (RNS) and they have sources in the myocardium. Redox homeostasis is dis-
turbed when oxidant species overcome the capacity to reduce of the cell. While excessive ROS 
results in oxidative stress; excessive RNS results in nitrosative stress. Potentially reactive spe-
cies such as the mitochondrial electron transport chain, xanthine oxidase, NADPH oxidases 
and nitric oxide synthases (NOS) are present in the myocardium. There are three NOS iso-
forms: NOS1 (neuronal NOS = nNOS), NOS2 (inducible NOS = iNOS) and NOS3 (endothelial 
NOS = eNOS). These isoforms are named according to the first description of the tissues. It 
AGTR1 and 
ACE2
Forward primer 5′-3′ Reverse primer 3′–5′
rs1492100 TTCAATAACAGATTCCCAGAG CCACCTCAACTTGCCTGTG
rs1492099 TTCAATAACAGATTCCCAGAG CCACCTCAACTTGCCTGTG
rs1492097 TTCAATAACAGATTCCCAGAG CCACCTCAACTTGCCTGTG
rs3772616 TGATAATTTATGTACTCCCTC CAAAGCATAAGTGTCAACAGA
rs6632677 CTGACTTGTTGCAGCAAGATGC TAGGAGTCCAGGCACAGTTCAG
PCR, polymerase chain reaction; SNP, single nucleotide polymorphism; AGTR1, angiotensin II receptor 1; ACE2, 
angiotensin-converting enzyme 2; Amp, amplification.
Table 1. Primer sequences used in PCR for AGTR1 and ACE2.
GENES amp. size (bp) Primer Primer sequences
AGT M235T 163 bp Forward 5′-CGTTTGTGCAGGGCCTGGCTCTC-3′
Reverse 5′-AGGGTGCTGTCCACACTGGACCC-3′
ACE AluI/D 490 bp Forward 5′-CTGGAGACCACTCCCATCCTTTCT-3′
Reverse 5′-GATGTGGCCATCACATTCGTCAGAT-3′
CYP112B2-344C/T 537 bp Forward 5′-CAGGAGGAGACCCCATGTGAC-3′
Reverse 5′-CCTCCACCCTGTTCAGCC-3′
PCR, polymerase chain reaction; AGT, angiotensinogen; ACE (I/D), angiotensin-converting enzyme (insertion/deletion); 
CYP112B2, aldosterone synthase; Amp, amplification.
Table 2. Primer sequences used in PCR and amplification product size for AGT, ACE (I/D) and CYP112B2-344C/T.
Gene Polymorphisms Associated with Atrial Fibrillation
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is known that enzymes that occur in NOS1 and NOS3 are expressed in the heart. NOS2 is 
expressed in inflammatory and pathological conditions such as hypertrophy or heart fail-
ure. While in cardiac myocytes, NOS1 and NOS3 were present in intracellular compartments, 
NOS2 is present in the cytosol of cardiac myocytes. NOS plays an important role in stimu-
lating effects of NO on guanylate cyclase, or in arising and mediating effects of nitrosation 
of tyrosine, cysteine residues. NO, which a highly reactive radical, is spreadable and its life 
is very short. l-arginine is converted to citrulline by NO production and is a substrate for 
NOS. NOS2 is expressed in macrophages, neutrophils, endothelial cells, vascular smooth 
muscle cells and cardiomyocytes. The competitive inhibition of endogenous methylarginine 
regulates the substrate level in NOS isoforms. Oxidative stress plays an important role in 
AF pathogenesis. NOS enzymes can be decomposed and transferred from NO production to 
superoxide anion, strong free radicals and oxidation. Therefore, NOSs that are associated with 
oxidative stress are important in AF pathogenesis. In the case development of AF, left atrial 
endocardial NOS reduction occurs. Thus, a significant reduction in NO production occurs. 
Clinical cohorts were performed to investigate the relationship between AF development and 
eNOS gene polymorphisms. In a study with a Caucasian population that developed AF, it was 
determined that eNOS T-786C, G894T and 4a/4b gene polymorphisms did not have genetic 
risk factors in the development of AF. In another study, while CC genotype of eNOS T-786C 
polymorphism was found to be a genetic risk factor for homocysteine concentrations, there 
was no significant relationship between this polymorphism and the risk of developing AF. In 
another study conducted with heart failure and AF patients, 894TT genotype of G894T gene 
polymorphism was determined as a genetic risk factor in development of AF. In a study con-
ducted by Giusti et al., eNOS T-786C gene polymorphism was found to be associated with a 
decrease in eNOS gene promoter activity. Furthermore, in the same study, this polymorphism 
was found to be an independent risk factor for plasma homocysteine concentrations [7–9]. It 
is presented primer sequences that used to determine eNOS T-786, G894T, Intron 4a/4b gene 
polymorphisms in Table 3.
4. Endothelin 2 A985G gene polymorphism
AF is an important complication of hypertrophic cardiomyopathy and is observed in approxi-
mately 20% of patients with hypertrophic cardiomyopathy. Hemodynamic changes following 
Genes amp. size (bp) Primer Primer sequences
eNOS T-786 180 bp Sense 5′-TGGAGAGTGCTGGTGTACCCCA-3′
Antisense 5′-GCCTCCACCCCACCCTGTC-3′
eNOS G894T 200 bp Sense 5′-AACCCCCTCTGGCCCACTCCC-3′
Antisense 5′-TCCATCCCACCCAGTCAA-3′
Intron 4a/4b 393 (4a) 420 (4b) Sense 5′-AGGCCCTATGGTAGTGCCTTT-3′
Antisense 5′-TCTCTTAGTGCTGTGGTCAC-3′
PCR, polymerase chain reaction; eNOS, endothelial nitric oxide synthase; Amp, amplification.
Table 3. Sequence of primers, size of the PCR products eNOS T-786C, G894T, Intron 4a/4b gene polymorphisms.
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sympathetic or parasympathetic activation play an important role in AF triggering. In a study 
conducted by Thomson et al., hypertension was reported to induce triggering in developing 
of AF in patients with hypertrophic cardiomyopathy. Since myocardial hypertrophy is pres-
ent in patients with hypertrophic cardiomyopathy, the left ventricular space is small in these 
patients. Thus, a decrease occurs in venous conversion and intravascular volume. As a result 
of this, in the patients with hypertrophic cardiomyopathy, low heart debit and various symp-
toms arise. Cheung et al. suggested that AF could be induced in the study they performed. 
Endothelin 2, which constricts the systemic vessels, protects venous return and prevents 
hypertension that may develop. Acute hypertension causes an increase in sympathetic nerve 
activity. Hypertension can occur in hypertrophic cardiomyopathy. A vasoconstrictor may 
show protective effect against AF in hypertrophic cardiomyopathy. Proximal AF is more com-
mon in hypertrophic cardiomyopathy than in other structural heart diseases. This monogenic 
disorder is a disorder affecting left ventricular hypertrophy in patients with hypertrophic car-
diomyopathy. These disorders result from mutations in genes encoding the sarcomeric pro-
teins. In a study conducted by Sharma et al., it has been shown that the endothelin 2 gene may 
be effective in the development of hypertension, and that this gene is expressed to in human 
atrial tissue. Endothelin 2 gene is localized on chromosome 1p34. It has been suggested that 
there is a significant relationship between hemodynamic changes and polymorphisms occur-
ring in endothelin 2 gene in patients with essential hypertension. The functional role of endo-
thelin 2 A985G gene polymorphism is not known precisely. mRNA stability is affected by 
variations in 3′-UTR. Thus, endothelin 2 transcription and translation may be affected in the 
endothelin 2 A985G gene polymorphism. Differences in A985 allele frequencies are observed 
in studies with different populations. Endothelin 2 A985G gene polymorphism plays a protec-
tive role for A985 allelic cardiovascular diseases, but this allele may trigger AF development 
in hypertrophic cardiomyopathic patients. In a study conducted by Nagai T et al., The endo-
thelin 2 A985T allele has been shown to be a genetic risk factor for the development of AF in 
hypertrophic cardiomyopathic patients [10]. It is presented primer sequences that used to 
determine Endothelin 2 A985G gene polymorphism in Table 4.
5. Connexins gene polymorphisms
AF can also occur when there is or no structural heart disease. Most of the foci that cause AF are at 
the site where combine the cardiomyocytes and vascular smooth muscle cells are located near the 
pulmonary venules. Connexins (Cx) are gap junction proteins and play an important role in direct 
cell-cell interactions in the majority of the tissues of the body in electrical conduction in the heart. 
It is known that there are 20 different Cxs in humans, and each Cxs create channels with different 
Genes Primer Primer sequences
Endothelin 2 A985G gene Forward 5′-ACAAACCAGGAGCAACCGTG-3′
Reverse 5′-AGGGAATGAGGGTGCAAGAA-3′
G allele-specific probe 5′-VIC-CCCTGGAGACTGGA-MGB-3′
A allele-specific probe 5′-FAM-CCGGAGGCTGGAT-MGB-3′
PCR, polymerase chain reaction.
Table 4. Sequence of primers for endothelin 2 A985G gene polymorphism.
Gene Polymorphisms Associated with Atrial Fibrillation
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characteristics and specific expression patterns. The polymorphisms occur in gap junction channels 
and in Cx proteins that play a role in action potential spread. Variants that occur in genes encoding 
variants that occur in genes encoding Cx40 and Cx37 that contribute to pulmonary vein-arrhyth-
mogenic affect gene expression and function. Cx40 and Cx37 that contribute to pulmonary vein-
arrhythmogenic affect gene expression and function. Variants that occur in genes encoding Cx40 
and Cx37 that contribute to pulmonary vein-arrhythmia affect gene expression and function. The 
Cx40 gene is encoded by GJA5 and is expressed in endothelial cells, coronary vascular smooth mus-
cle cells, atrial cardiomyocytes and cardiac conduction systems. In GJA5, the TATA box sequence 
also changes is the result of the single nucleotide polymorphism found in the promoter region. 
Cx40 gene modulates broad mRNA levels and is known to be associated with AF. In a previous 
study, Cx40-26G>A gene polymorphism-26G allele was identified as a genetic risk factor in patients 
with cardiomyopathy AF. In a study performed by Carballo et al., Cx40-26G>A gene polymor-
phism was found to affect protein expression levels in cardiomyocytes and this polymorphism was 
associated with structural AF. There are significant relationships between polymorphisms occur-
ring in GJA5 in the Cx40 gene and susceptibility to AF. Somatic mutations in the Cx40 gene have 
also been associated with idiopathic AF. The Cx43 gene is also encoded by GJA1 and is expressed 
by ventricular, atrial cardiomyocytes, vascular smooth muscle cells, endothelial cells, monocytes 
and macrophages. Other genes and polymorphisms associated with polymorphisms in the CX43 
gene have also been reported to be effective in the development of AF. The Cx37 gene is encoded by 
GJA4 and is found in endothelial cells, pulmonary and vascular smooth muscle cells, monocytes/
macrophages and platelets. Polymorphisms occurring in GJA4 in the Cx37 gene are associated with 
atherosclerosis and coronary heart disease, and these polymorphisms have an effect on monocyte 
adhesion. Thus, they are important in the regulation of local inflammation. Systemic and local 
inflammation may play a role in the development of AF before or after surgery in some cases. The 
1019 C>T gene polymorphism in the CX37 gene in GJA4 is characterized by proline/serine (P319S) 
substitution at position 319 in the cytoplasmic tail of the Cx37 gene. As a result, channel conductiv-
ity and permeability change. Cx37 1019 C>T gene polymorphism is also associated with platelet 
aggregation or monocyte adhesion. Due to the effect of this polymorphism on monocyte adhesion, 
sensitivity to non-structural AF may change [11–13]. It is presented primer sequences that used to 
determine Cx37 1019 C>T, Cx40 G-44A gene polymorphisms in Table 5.
6. Gamma-glutamyl carboxylase gene polymorphism
Warfarin, an oral anticoagulant, is used in the correction of various thromboembolitic dis-
orders such as prosthetic heart valves, deep vein thrombosis and pulmonary embolism. 
Genes Primer Primer sequences
Cx37 1019 C>T Forward 5′-CTGGACCCACCCCCTCAGAATGGCCAAAGA-3′
Reverse 5′-AGGAAGCCGTAGTGCCTGGTGG-3′
Cx40 G-44A Forward 5′-CCCTCTTTTTAATCGTATCTGTGGC-3′
Reverse 5′-GGTGGAGGGAAGAAGACTTTTAG-3′
PCR, polymerase chain reaction; Cx, connexin.
Table 5. Sequence of primers for the connexins.
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Thromboembolism or bleeding may develop as a result of inadequate or excessive intake of 
warfarin. Discomforts such as stroke and systemic thromboembolism can be reduced with 
anticoagulant treatments. Factors such as age, body size, environment, interacting drugs 
and gene polymorphisms are effective at warfarin dose requirements. Stable warfarin dose 
is affected by gene polymorphisms such as single nucleotide gene polymorphism. These 
polymorphisms play a role in the modulation of warfarin pharmacodynamics and pharma-
cokinetics. Gamma carbon carboxylation occurs on gamma glutamic acids. Gamma-glutamyl 
carboxylase (GGCX) found in the endoplasmic reticulum membrane oxidizes vitamin K-2,3 
epoxite reduced vitamin K. Therefore, functional vitamin K-dependent clotting factors (II, 
VII, IX and X) are produced by this enzyme. GGCX catalyzes the biosynthesis of vitamin 
K-dependent clotting factors. Thus, this enzyme affects warfarin metabolism. Warfarin 
metabolism, one of the most frequently used anticoagulants in clinical therapy, is affected by 
the GGCX enzyme. GGCX is a gene that plays an important role in the individual differences 
of warfarin response. Warfarin is a common anticoagulant that a narrow therapeutic range. 
Genetic factors that play an important role in warfarin dose requirements include GGCX 
gene polymorphisms. GGCX gene that consisted of 15-exon is located on human chromo-
some 2p12. It has been reported that there is a relationship between polymorphisms occurring 
in the GGCX gene and warfarin dose variability. GGCX rs11676382, rs12714145, rs10654848 
and rs699664 gene polymorphisms are the most common polymorphisms of the GGCX gene. 
GGCX rs11676382 (C>G) gene polymorphism found in intron 14 was found to be associated 
with low Warfarin dose requirements in the Caucasus. In intron 2, GGCX rs12714145 (3261G>A) 
gene polymorphism was found to have more warfarin dose requirements in Chinese patients 
with the AA genotype. In Caucasians and African Americans, there is a significant relation-
ship between GGCX rs10654848 microsatellite (DNA repeats) gene polymorphism in intron 6 
and high warfarin dose requirements. GGCX rs699664 gene polymorphism, characterized by 
a G/A base substitution at the 8th exon. This displacement results in the arginine/glutamine 
amino acid exchange at position 325. In Japanese and Chinese patients, a significant relation-
ship was determined between this polymorphism and high warfarin dose requirements. In 
contrast, in Caucasians or African Americans, this gene polymorphism was found not to be 
associated with warfarin dose. In AF patients, it was determined that GGCX rs699664 gene 
polymorphism was significantly correlated with GA, AA genotypes and high warfarin dose 
requirements. Another polymorphism associated with warfarin dose in patients with AF is 
the GGCX rs2592551 gene polymorphism. The effect of GGCX rs2592551 gene polymorphism 
on the warfarin dose was investigated in a study conducted by Kamali et al. in a population 
living in the Xinjiang region (region of multiple ethnic communities of Khan, Uyghur, Kazakh, 
Hui, Kyrgyz, Mongol and Tajik). In this study, CT and TT genotypes of GGCX rs2592551 gene 
polymorphism were found to be associated with higher warfarin dose requirements than CC 
genotype in patients with AF [14, 15]. It is presented primer sequences that used to determine 
GGCX rs699664, rs2592551 gene polymorphisms in Table 6.
Genes Forward primer (5′–3′) Reverse primer (5′–3′)
rs699664 AGTGGCCTCGGAAGCTGGT ACACAGGAAACACTGGGCTGAG
rs2592551 GGACTTAGAAAGGAACGGATGA CTTGAGAAAAGGCAAAGCAGAC
PCR, polymerase chain reaction; SNP, single nucleotide polymorphism; GGCX, gamma-glutamyl carboxylase.
Table 6. Primer sequences used in PCR for GGCX.
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7. G-protein β3 subunit C825T gene polymorphism
G-protein β3 subunit C825T gene polymorphism plays an important role in the change of elec-
trophysiological properties of human atrium. This polymorphism occurs in 10th exon of gene, 
which encodes the G-protein β3 subunit. It has been determined by Siffert et al. that this poly-
morphism is a genetic risk factor in the development of hypertension. Increased human atrial 
internal rectifier regulatory potentials have been associated with the TT genotype of G-protein 
β3 subunit C825T gene polymorphism. There is also a significant relationship between the TT 
genotype of the G-protein β3 subunit C825T gene polymorphism and the increased internal 
rectifier flow and reduced acetylcholine stimulating potassium flux in the human atrium. In 
the European white population, 825 T allele of G-protein β3 subunit C825T gene polymor-
phism was found to be significantly associated with various cardiovascular disorders such as 
increased obesity, hypertension, left ventricular hypertrophy and coronary artery disease. In 
a study performed by Schreieck et al., heterozygote T and homozygote T allele carriage were 
found to be low risk factors for AF development. G-protein β3 subunit the TT and CT geno-
types of the C825T gene polymorphism play an important role in atrial cellular electrophysi-
ological changes. In a study conducted by Dobrev et al., it was determined that TT genotype 
of this polymorphism correlates with the downregulation of acetylcholine mRNA transcripts 
in human atrial myocytes. Although there is no relationship between G-protein β3 subunit 
C825T gene polymorphism and any arrhythmia, in some studies this polymorphism has been 
associated with the risk of developing AF. In conclusion, gene polymorphisms encoding ion 
channels are very important in AF pathogenesis. Identification of these polymorphisms will 
elucidate the multigenic mechanism of AF predisposition [16]. It is presented primer sequences 
that used to determine G-protein β3 subunit C825T gene polymorphism in Table 7.
8. Polymorphisms in the genes coding ion channels
8.1. KCNN3 rs13376333 gene polymorphism
Differences in populations due to myocardial membrane stability, conduction routes or 
genetic polymorphisms are important factors in predisposing to AF development. In recent 
association studies, gene polymorphisms found on chromosomes 4q25, 16q22 and 1q21 have 
been identified as genetic risk factors for AF development. Moreover, these genetic variants 
Genes Primer Primer sequences
G-protein β3 subunit C825T 
gene
Forward 5′-TTCTCCCACGAGAGCATCATCT-3′
Reverse 5′-GTCGTCGTAGCCAGCGAATAGTA-3′
Allele 825C probe 5′-CATCACGTCCGTGGCCTTCTCC-3′
Allele 825T probe 5′-CATCACGTCTGTGGCCTTCTCCCT-3′
PCR, polymerase chain reaction.
Table 7. Sequence of primers for G-protein β3 subunit C825T gene polymorphism.
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are more important in the development of early onset AF. The relationship between these 
gene polymorphisms and the risk of developing AF has been explored in different popula-
tions. From these populations, in one Chinese and European origin considerable differences 
have been found in terms of these polymorphisms. rs2200733 on the 4q25 chromosome and 
rs106261 gene polymorphisms on the 16q22 chromosome have been observed quite often in 
the Chinese population in particular. However, the relationship between the rs7193343 gene 
polymorphism on the 16q22 chromosome and the risk of developing AF was not significant 
in the Chinese Han population. In a study conducted by Ellinor et al. with the European 
population, KCNN3 single nucleotide gene polymorphism, which is associated with AF in the 
new genetic locus, has been discovered in the potassium medium/small conductance calcium-
activating channel. The KCNN3 gene encodes voltage-independent calcium and activated 
potassium channels. The KCNN3 rs13376333 gene polymorphism is located between the first 
and second exons of the KCNN3 gene. There are three subtypes of potassium channels as 
SK1, SK2 and SK3. Atrial myocytes are formed by the subunits of these channels to form 
heteromultimeric complexes. The expression of SK3 channels is similar to the expressions 
of SK1 and SK2 channels. There are studies showing that the relationship between these SK 
channels and AF is significant. However, more studies are needed to determine the role of 
SK3 channels in AF development. Studies were also conducted in the Asian population to 
investigate AF associations with KCNN3 gene polymorphisms, which are the ionic channel 
gene identified in AF GWAS. However, a large number of replication studies are needed to 
determine this relationship. In a study conducted by Chang et al., KCNN3 rs13376333 gene 
polymorphism in the Taiwanese population was found to be an important risk factor for the 
development of AF. Also Ellinor et al. showed that there is a significant association between 
AF and KCNN3 rs13376333 gene polymorphism. In a study conducted with Chinese Han 
population, KCNN3 rs13376333 gene polymorphism has not been identified as a genetic risk 
factor in the development of AF. In Taiwan and China populations, the T allele of KCNN3 
rs13376333 gene polymorphism was observed at a significantly lower frequency [17].
8.2. SCN10A gene polymorphism
Voltage-gated sodium channels play an important role in impulse generation and conduction 
during the rising phase of action potential in excitable cells. There are sodium channel iso-
forms in the heart. These channels include voltage-gated sodium 1.1, voltage-gated sodium 
1.3, voltage-gated sodium 1.5 (Nav1.5), voltage-gated sodium 1.6 and voltage-gated sodium 1.8 channels. The Nav1.5 encoded by SCN5A is responsible for the regulation of cardiac con-duction. The Nav1.5 channel plays a very important role in cardiac impulse spread. As a 
result of the activation of sodium channels, the cardiac action potential is rapidly increasing. 
Each sodium channel consists of an α subunit and modulating β subunits. The α subunit of 
the NaV1.5 channel is encoded by the SCN5A gene. Each of the Nav1.5 α subunit consists 
of 4 homologous domains (DI-DIV) with 6 transmembrane alpha helices (S1-S6). The S1-S4 
domains are repeatable and these domains constitute the voltage sensing areas of the channel. 
The functional pore and selectivity filter of the sodium channel consists of S5, S6 and S5-S6 
loops. More than 300 mutations have been identified in the SCN5A gene. SCN5A mutations 
determined to be associated with Brugada Syndrome (BrS) lead to variable reductions in the 
sodium flow inward with channel transit changes. These channel passing changes delayed 
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activation, increased inactivation, slow recovery from inactivation, or impaired exchange of 
channel. As a result, decrease in expression occurs in the cell membrane. Consequently, these 
mechanisms cause loss of function in the cardiac sodium channel. The most common geno-
type found among BrS patients stems from mutations in the SCN5A gene. As a result of these 
mutations occurring in the gene, there is a loss of function in the cardiac sodium channel 
through different mechanisms. Depolarization or repolarization of cardiac action potential 
may be affected by due to reduced sodium current. Nevertheless, the underlying pathophysi-
ological mechanism of the BrS phenotype is still being discussed [18]. BrS is defined as a dis-
ease characterized by sudden cardiac death characterized by a right bundle branch with an ST 
segment elevation in leads V1 and V2 in 1992. This syndrome was found to be associated with 
sudden cardiac death, especially in young men [19]. BrS, determined to be genetic, is a cardiac 
electrical disorder. BrS, an arrhythmogenic and autosomal dominant inherited cardiac syn-
drome, is characterized by typical electrocardiographic changes. In a study conducted in the 
Chinese population, localized in the domain II S4 segment of NaV1.5 α subunit protein, a new 
mutation, L812Q mutation, has been described. In this study, it was shown that this mutation 
improved the sodium channel inactivation process and disrupted the membrane expression 
of the canal in BrS patients [18]. In a Dutch population study, it was determined that SCN5A 
gene mutations, which cause loss of function in BrS patients, are associated with dilation and 
deterioration in contractile function of both ventricles [20]. In another study, SCN5A showed 
a high penetrance for BrS in a large family with the E1784K mutation. In addition, in the 
same study, overexpressing phenotypes of BrS were shown in E1784K and H558R carriers 
after the fourth decades of their lifes [21]. There is an effect in the cardiac electrophysiologi-
cal properties of sodium-gated voltage channel 1.8 via the effect intrinsic on cardiac ganglion 
neurons. In the isolated ventricular myocardium, it is known that the sodium-gated voltage 
1.8 channel is not expressed. In isolated intrinsic cardiac ganglia, there are immunoelectro-
chemical studies indicating that significant amounts of sodium-gated voltage 1.8 channels 
are expressed. Facer et al. have shown that sodium-gated voltage 1.8 channel immunoreac-
tive sensory nerves are present in human atrial myocardium. Voltage-gated sodium 1.8 chan-
nel is encoded by SCN10A and is a tetradoxin (TTX)-resistant sodium channel. This channel 
is expressed in dorsal root ganglia, cranial sensory ganglion sensory neurons. The SCN10A 
gene, which contains 27 exons, is localized on chromosome 3q22.2. The SCN10A gene has been 
shown to be associated with cardiac transmission. Because the SCN10A gene plays a role in 
increasing the PR interval and QRS duration in the electrocardiogram. Therefore, it was found 
that there is a relation between SCN10A and AF development. The SCN10A sodium-gated 
voltage 1.8 channel plays an important role in modulating the induction of AF. Verkerk et al. 
have demonstrated that the SCN10A sodium-gated voltage 1.8 channel is present in intrin-
sic cardiac neurons. In a study conducted by Chambers et al., a significant relationship was 
found between SCN10A rs6795970 gene polymorphism and PR interval. SCN10A rs6795970 
(G>A) gene polymorphism is a missense mutation and causes an A1073V amino acid substitu-
tion in the sodium-gated voltage channel 1.8 IDII/III intracellular cycle. In a study conducted 
by Ritchie et al., the G allele of SCN10A rs6795970 gene polymorphism was found to be a 
genetic risk factor for the development of AF. In another study performed by Sabbari et al., G 
allele of SCN10A rs6795970 gene polymorphism was associated with increased risk of AF. A 
significant association was found between the SCN10A rs6800541 gene polymorphism and 
AF development in the study conducted by Pfeufer et al. [22, 23].
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8.3. KCNE1 G38S gene polymorphism
KCNE1 widely known as a potassium ion channel encoding gene for humans and it is local-
ized on chromosome 21q22.1–21q22.2 encoding the subunit of the potassium ion channel (IKs). 
KCNE1 plays an important role in atrial and ventricular repolarization. The KCNE1 gene was 
discovered by Murai et al. in 1989. Studies have shown that KV7.1, the α subunit of the IKS cur-
rent, plays an important role in AF pathogenesis. The regulatory β subunits of the IKS current 
also bind to the KCNE1 gene. Biophysical properties of these β subunits of KV.71 can be altered 
by expression together. The β subunits of IKS contain 130 amino acids, which is called the Mink 
protein. Several single nucleotide gene polymorphisms have been identified in the KCNE1 gene. 
The most common of these polymorphisms is the KCNE1 G38S (rs1805127 G>A, G38S) poly-
morphism. The KCNE1 gene polymorphism is characterized by a glycine or serine amino acid 
substitution in the 38th position of the gene. As a result, stronger IKs flows occur. Various studies 
have been carried out to demonstrate that the KCNE1 gene and polymorphisms are highly effec-
tive in AF pathogenesis. In a study conducted by Lai et al., a significant association was found 
between the risk of developing AF in the Taiwanese population and the KCNE1 G38S gene poly-
morphism. Despite this conclusion in the Taiwanese population, it has been determined that 
this polymorphism is not a genetic risk factor in the development of AF in the Chinese popula-
tion. Studies conducted with European and Uighur populations have also found that KCNE1 
G38S polymorphism is a risk factor associated with AF. A total of 14 studies were conducted to 
investigate the relationship between KCNE1 G38S gene polymorphism and the risk of devel-
oping AF. In eight of these studies, a significant relationship was found between the risk of 
developing KCNE1 G38S gene polymorphism and AF. However, no significant relationship was 
determined in other six studies. In a meta-analysis study conducted by Jiang et al., to evaluate 
the relationship between KCNE1 G38S polymorphism and AF, it is concluded the KCNE1 G38S 
gene polymorphism increased AF risk. In a study carried out by Yadav et al., in the North Indian 
population, KCNE1 G38S gene polymorphism was found to be not a risk factor for postoperative 
AF development. In a study by Chen et al., it was found that the arrhythmia matrix is important 
SNP rs Forward primer (5′–3′) Reverse primer (5′–3′)
KCNN3
rs13376333
TGAGAGCACCTGCAGACATC GCAGCAAGAAGTGGGTCAAT
SCN10A-1
rs6795970
ATGACCCGAACTGACCTTCC TGACGCTAAAATCCAGCCAGT
SCN10A-2
rs6795970
TGACAGAGGAGCAGAAGAAATACTACA GTTGAGGCAGATGAGGACCA
KCNE1
rs1805127
GTGACGCCCTTTCTGACCAA CCAGATGGTTTTCAACGACA
KCNE1
rs1892593
TGGGCTCTATTTTCAG CCATTGGTCATTTTCC
PCR, polymerase chain reaction; SNP, single nucleotide polymorphism.
Table 8. Primer sequences used in PCR for polymorphisms in the genes coding ion channels.
Gene Polymorphisms Associated with Atrial Fibrillation
http://dx.doi.org/10.5772/intechopen.76920
15
at the onset or maintenance of AF. The arrhythmia matrix is formed by the interaction of proteins 
encoded by KCNE1 with other proteins. Therefore, the KCNE1 gene plays a very important role 
in regulating cardiac rhythm. Studies involving subgroup analyzes also found that the risk of 
developing AF in white populations with risk alleles was higher than in the Chinese population. 
The pathogenesis of AF is unknown. However, as a result of mutations in the genes encoding 
the ion channel, AF can develop due to a decrease in IKs. Environmental factors and genetic fac-
tors play a role in the pathogenesis of AF. It has been determined that different polymorphisms 
in genes encoding ion channels other than the KCNE1 G38S gene polymorphism may also be 
important risk factors for AF development [24, 25]. It is presented primer sequences that used to 
determine polymorphisms in the genes coding ion channels in Table 8.
9. RPL3L and MYZAP gene polymorphisms
A polygenic process involving transcription factors, cardiac ion channels, myocardial and 
cytoskeletal proteins plays an important role in AF pathogenesis. Based on the entire genome 
sequence, GWAS has shown that three low-frequency coding variants are effective in the devel-
opment of AF. The myosin sarcomeric genes MYH6 and MYL4, the cytoskeletal gene PLEC, are 
these variants. MYH6, MYL4 and PLEC genes also encode cardiomyocyte structural compo-
nents such as MYZAP. Ribosome activity can be specifically regulated in the cell via changes 
in the ribozyme protein composition. The eukaryotic ribosome consists of 4 different ribosomal 
RNAs and about 80 ribosomal proteins. This ribosome plays an important role in translating the 
messenger mRNA into a protein. Ribosomal proteins or genes encoding ribosome biogenesis 
factors may result in mutations leading to ribosomopathy, a hereditary disease. It is known that 
RPL3L-containing ribosomes may cause translational activity changes. Among RPL3L missense 
mutations, a negative regulator of muscle growth, p.Ala75Val and p.Gly12Arg mutations are 
important. Apart from these mutations, the RPL3L c.1167+1G>A mutation is involved in the 
impairment of the interaction of RPL3L with endoplasmic reticulum. As a result of these muta-
tions, the risk of developing AF is increasing. Human Myozap mRNA is expressed primarily in 
the heart. Myozap regulates serum response factor signaling in the nucleus. This is why it plays 
an important role in cardiac signal transduction. Mutations in intercalated disk genes result in 
cardiomyopathies and sudden cardiac deaths that are a significant risk for AF. AF variants are 
defined in the genes coding for components of intercalated discs and in the vicinity of these genes. 
Seeger et al. found the MYZAP gene in the components of intercalated discs. Intercalated discs 
are a cell-cell contact structure that provides mechanical, electrical and chemical communication 
between cardiomyocytes. The risk of AF is also increasing as a result of MYZAP p.Gln254Pro 
gene polymorphism. In a previous study, there was a significant relationship between four low-
frequency coding variants in the RPL3L and MYZAP genes and the risk of developing AF. The 
missense variant in MYZAP was identified as a genetic risk factor in the development of AF [26].
10. Gene polymorphisms and C-reactive protein levels related to 
inflammation
Several studies have been carried out to investigate the relationship between inflammation and 
AF. These studies have led to the conclusion that inflammation may cause AF or play an important 
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role in the onset and maintenance of AF. Myocarditis, pericardiotomy and C-reactive protein 
(CRP) levels were associated with AF, a dysrhythmia, in studies conducted. However, in some 
other studies, it has been determined that there is a relationship between AF and the induction 
of inflammatory response. Previous studies have suggested that AF may be due to inflammatory 
processes and there is a significant relationship between the CRP levels and the risk of develop-
ing AF in these studies. A study performed by Lo et al. found a significant relationship between 
high basal CRP levels and increased postoperative AF risk. Non-Willebrand factor expression, 
which is effective in tissue factor, fibrinogen, factor VIII and prothrombic state, is induced by the 
IL-6 gene, which plays an important role in inflammation. Another study by Gaudino et al. found 
that −174 G/C polymorphism, a polymorphism in the promoter region of the interleukin-6 (IL-6) 
gene, was a significant effect on the inflammatory response and was associated with the risk of 
postoperative AF development. Also Marcus et al., in their study showed a significant relation-
ship between increased IL-6 levels and the risk of developing AF. There is also a study showing 
that patients with high CRP levels have higher AF risk than patients with normal CRP levels [27].
11. Gene polymorphisms on chromosome 4q25
There are four unique nucleotide polymorphisms on the 4q25 chromosomal region, rs2200733, 
rs2220427, rs2634073 and rs10033464, and in studies conducted in European and Chinese pop-
ulations, a significant relationship was found between these polymorphisms and the risk of 
developing AF. There are no known biological roles of these single nucleotide polymorphisms. 
These polymorphisms near to the homedomain transcription factor 2 (PITX2) gene and poten-
tially alter the function of this factor. PITX2 is involved in the cardiac pathogenesis of ischemic 
and pulmonary venous access pathways. rs2200733 and rs13143308 that among the polymor-
phisms found on the 4q25 chromosome have also been identified as genetic risk factors for 
AF development. There are also several epidemiological cohorts recently showing a signifi-
cant association between rs2200733, rs10033464 single nucleotide polymorphisms located in 
the 4q25 chromosome and AF development. In a recent study, rs2200733 polymorphism was 
found to be a genetic risk factor for AF development, proliferation and recurrence [28].
12. PRRX1 rs3903239 gene polymorphism
PRRX1 (paired-related HomeBox 1) is a gene encoding homedomain transcription factor that 
is expressed high in the developing heart. As a result of GWAS, the molecular mechanisms 
related to AF have been tried to be elucidated. In a recent meta-GWAS, significant correlations 
were found between the risk of developing rs3903239 polymorphism and AF on the 1q24 chro-
mosome of the PRRX1 gene. In another study conducted with the Greek population, the role of 
the genetic interaction between PRRX1 rs3903239 and PITX2 rs2200733 gene polymorphisms 
in the development of AF was investigated and no significant interaction could be detected 
between these polymorphisms in AF patients. In addition, there was no significant difference 
in terms of PRRX1 rs3903239 allele frequencies and genotypes between AF patients and healthy 
controls in the same study. In another study conducted with the Chinese population, PRRX1 
rs3903239 gene polymorphism was not detected as a significant genetic risk factor for AF [29].
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13. β-fibrinogene 455G/A gene polymorphism
Various studies have been conducted to investigate the relationship between β-fibrinogen 455G/A 
polymorphism and ischemic stroke in different populations. In a study conducted by Kessler 
et al., the AA genotype of the β-fibrinogen 455G/A polymorphism was more observed in patients 
with major vascular infarction. In a study conducted by Nishiuma et al., in a Japanese population, 
A allele of β-fibrinogen 455G/A polymorphism was identified as an independent risk factor for 
hypertensive patients. In a study conducted by Martiskainen et al., a significant association was 
found between the A-allele and the lacunar infarction susceptibility in the β-fibrinogen 455G/A 
polymorphism. In a study conducted by Zhang et al., in the Chinese population, β-fibrinogen 
455G/A polymorphism was found to be a genetic risk factor in the development of ischemic 
stroke. There are some meta-analysis studies showing that β-fibrinogen 455G/A polymorphism 
is associated with ischemic stroke in Chinese or Asian populations. A number of studies have 
been conducted to determine the association between this polymorphism and ischemic stroke, 
but no study has shown genetic effects in the pathogenesis of cardioembolic stroke in AF patients. 
The role of β-fibrinogen 455G/A polymorphism in cardioembolic stroke pathology is unclear. 
Promoter elements play an important role in regulating gene transcription. Transcription factor 
binding sites and transcription initiation rates can be varied by a promoter variant. β-fibrinogen 
455G/A polymorphism has an important stimulatory effect on the rate of basal and induced tran-
scription rate of the β-fibrinogen gene. There is a significant association between A allele of this 
polymorphism and increased promoter activity. β-Fibrinogen 455G/A polymorphism is one of 
the genetic polymorphisms associated with an increase in plasma fibrinogen. The increase in 
fibrinogen levels of individuals with A allele is greater than the increase in fibrinogen levels of 
individuals with G allele. Therefore, A allele of β-fibrinogen 455G/A polymorphism was found to 
be associated with higher fibrinogen level. Platelet aggregation, fibrinogen, an important deter-
minant of blood viscosity, is a component that plays a role in the coagulation cascade. As a result 
of elevated fibrinogen levels, thrombosis progresses and coagulation increases. In animal studies, 
fibrinogen applications have been shown to increase thrombosis and embolic status at increasing 
doses. In addition, it is known that fibrinogen has been implicated in triggering various inflam-
matory processes. As a basic component of inflammation, fibrinogen can cause impairment of 
thrombus plaque and is effective in the development of ischemic stroke. As a result of all these 
events, hemorheological disorders occur. As a result of all these events, hemorheological disor-
ders occur. Other polymorphisms that occur in the fibrinogen gene may also cause high fibrinogen 
concentrations such as β-fibrinogen 455G/A polymorphism β-fibrinogen 455G/A polymorphism 
has also been proven to be ineffective in the development of thrombotic events. In a study carried 
out by Xiaofeng Hu et al., in Chinese AF patients, proved that there is a relationship between 
increased risk of cardioembolic stroke and β-fibrinogen 455G/A polymorphism [30].
14. MTHFR (C677T and A1298C) and MTR A2756G gene 
polymorphisms
Hyperhomocysteinemia plays an important role in the pathogenesis of nonvalvular AF. 
Hyperhomocysteinemia develops as a result of polymorphisms occurring in genes encoding 
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homocysteine metabolism. These polymorphisms are thought to be effective in the devel-
opment of nonvalvular AF, which is the most common arrhythmia in clinical practice. 
Homocysteine is a highly reactive, sulfur-containing amino acid that occurs as a product 
of the essential amino acid methionine. Gene polymorphisms known to be associated with 
homocysteine occur in genes encoding enzymes that play a role in the metabolism of homo-
cysteine. Of these polymorphisms, MTHFR C677T and A1298C gene polymorphisms are 
associated with a decrease in MTHFR enzyme activity. In addition to these polymorphisms, 
there is also the MTR A2756G gene polymorphism. Homocysteine plays an important role in 
the pathogenesis of AF and there are studies showing that there is a significant relationship 
between increased homocysteine levels and AF. In some studies, there was a significant rela-
tionship between MTHFR C677T gene polymorphism and increased plasma homocysteine 
levels in patients with low folate levels. There are few studies related to MTHFR A1298C 
and MTR A2756G polymorphisms. In a study conducted by Betti Guisti et al., there was a 
significant relationship between plasma total homocysteine levels and MTHFR C677T gene 
polymorphism genotype distributions in patients with nonvalvular AF. Furthermore, no sig-
nificant relationship was observed between plasma total homocysteine levels and MTHFR 
1298AA and MTR 2756GG genotypes in nonvalvular AF patients. Given the combined geno-
type distributions, it is known that the MTHFR C677T and A1298C gene polymorphisms are 
related to each other [31]. It is presented primer sequences that used to determine MTHFR 
(C677T and A1298C) and MTR A2756G gene polymorphisms in Table 9.
15. Conclusion
Different results have been obtained in gene polymorphism studies to explain the pathogenesis 
of AF in which environmental and genetic factors play a role together. Differences in the results 
of these studies may result from different selection criteria for patients and control groups. 
Moreover, the findings obtained from these studies are different from each other because they 
are carried out with different races and populations. Identification of genes associated with AF 
and polymorphisms that occur in these genes will allow us to have information about the under-
lying mechanisms of the disease in susceptibility to this disease. Identification of candidate genes 
that play a role in genetic susceptibility to AF will be mentor to the prevention of this disease 
and the development of new therapies for disease. In order to be able to explain the pathogenesis 
of AF and to develop appropriate therapies for this disease, comprehensive studies should be 
conducted with different populations and with a large number of patients and control groups.
Genes Forward primer (5′–3′) Reverse primer (5′–3′)
MTHFR C677T biotinTGAAGGAGAAGGTGTCTGCGGGA CCACTCCAGCATCACTCACT
MTHFR A1298C biotinCAAGGAGGAGCTGCTGAAGA CTTGAGAAAAGGCAAAGCAGAC
MTR A2756G CATGGAAGAATATGAAGATATTAGAC biotinGAACTAGAAGACAGAAATTCTCTA
PCR, polymerase chain reaction; SNP, single nucleotide polymorphism; MTHFR, methylenetetrahydrofolate reductase; 
MTR, methionine synthase reductase.
Table 9. Primer sequences used in PCR for MTHFR C677T and A1298C, MTR A2756G.
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